Andrea Jimena Gutiérrez-Peredo

Andrea Jimena Gutiérrez-Peredo

Auto-generated profile, based on publicly available information

Andrea Jimena Gutiérrez-Peredo

Professor Edgard Santos Hospital University, Federal University of Bahia, Salvador, Brazil

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 November 2024 in BMC Nephrology
Verified
Journal Article
Open access
PDF file
GGGabriel Brayan Gutiérrez-Peredo
Gabriel Brayan Gutiérrez-Peredo
IMIris Montaño-Castellon
Iris Montaño-Castellon
AGAndrea Jimena Gutiérrez-Peredo
Andrea Jimena Gutiérrez-Peredo
MLMarcelo Barreto Lopes
Marcelo Barreto Lopes
FTFernanda Pinheiro Martin Tapioca
Fernanda Pinheiro Martin Tapioca
ALAntônio Alberto Da Silva Lopes
Antônio Alberto Da Silva Lopes
The 24-h urine protein (24-hUP) excretion is the gold standard for evaluating proteinuria. This study aimed to evaluate the diagnostic efficacy of protein/creatinine ratio (PCR) for estimating 24-hUP at various levels of renal function and proteinuria levels. A cross-sectional study was conducted between December 2021 and December 2023 in Salvador, Bahia-Brazil, as an extension of previously published data from the TUNARI study. The study included 217 samples from 152 patients with various levels of renal function and proteinuria. PCR in isolated samples and 24-hUP were determined conventionally within a 24-h timeframe. Patients were classified into three groups according to the level of renal function (Group 1 = 10 to < 30 mL/min, Group 2 = 30–60 mL/min, and Group 3 = > 60 mL/min) and level of proteinuria (< 0.3 g/day, 0.3–3.5 g/day, and > 3.5 g/day). The data were analyzed using the Spearman correlation (rs), coefficient of determination (r2), Bland–Altman plots and receiver operating characteristic (ROC) curve. Likelihood ratios, positive (LR +), and negative (LR-) were derived from the sensitivity and specificity of PCR. Mean age was 41.5 ± 15.7 years, 61.8% were women, 36.8% Black and 52% Mixed-race. Glomerulopathies constituted 80.3%; 46.1% with lupus nephritis. Of the total urine samples, we observed a high correlation between PCR in the total sample of 24-hUP sample (rs = 0.86, p < 0.001) across different levels of renal function. However, agreement between PCR and 24-hUP was reduced at higher levels of proteinuria. The ROC analysis showed an AUC of 0.95 (95% CI = 0.92, 0.98), sensitivity of 91% and specificity of 86.5% (LR + 6.7; LR- 0.1), with an optimal cut-off of 0.77. These results were similar across renal function levels. Proteinuria ≤ 0.3 g/day showed a high sensitivity of 83.3% and specificity of 90%, with an area under (AUC) of 0.85 (95% CI = 0.71; 0.94). In the 24-hUP range > 0.3–3.5 g/day, the sensitivity was 64.1%, the specificity was 84.6%, and the AUC was 0.76 (95% CI = 0.67; 0.84), PCR detected all cases > 3.5 g/day. PCR is a suitable measure to be used as an indicator of 24-hUP at different levels of renal function, but may have limitations at higher levels of proteinuria. Analysis of PCR by proteinuria level found that agreement as well as sensitivity decreases at higher levels, but it maintains good specificity and is able to identify nephrotic range proteinuria.

1 November 2021 in Nefrología
Verified
Journal Article
Open access
GNGlivia Renata Silva Novaes
Glivia Renata Silva Novaes
GGGabriel Brayan Gutiérrez-Peredo
Gabriel Brayan Gutiérrez-Peredo
IMIris Montaño-Castellon
Iris Montaño-Castellon
AGAndrea Jimena Gutiérrez-Peredo
Andrea Jimena Gutiérrez-Peredo
MJMiguel Nino Labanca Júnior
Miguel Nino Labanca Júnior
SAStenio Cerqueira de Ataide
Stenio Cerqueira de Ataide

11 February 2025 in Nephron
Verified
Journal Article
Open access
GGGabriel Brayan Gutiérrez-Peredo
Gabriel Brayan Gutiérrez-Peredo
AGAndrea Jimena Gutiérrez-Peredo
Andrea Jimena Gutiérrez-Peredo
IMIris Montaño-Castellon
Iris Montaño-Castellon
MNMarinho Marques da Silva Neto
Marinho Marques da Silva Neto
FSFernanda Albuquerque da Silva
Fernanda Albuquerque da Silva
ALAntônio Alberto Da Silva Lopes
Antônio Alberto Da Silva Lopes
Background: Patients with chronic kidney disease undergoing maintenance hemodialysis (MHD) have an increased mortality. The CHA2DS2-VASc score, initially used for stroke prediction in atrial fibrillation, is relevant for various cardiovascular conditions. This study evaluates its effectiveness in predicting cardiovascular and all-cause mortality in MHD patients. Methods: Data are from the “Prospective Study of the Prognosis of Patients on Chronic Hemodialysis” (PROHEMO) in Salvador, Brazil. Patients were divided by CHA2DS2-VASc scores: ≤2 and >2. Cox regression estimated hazard ratios (HR) for death, both unadjusted and adjusted for confounders. We assessed the distribution of each score variable and its association with mortality. A modified CHA2DS2-VASc score was created due to the low percentage of patients over 75 (1.3%) and normotensive (4.6%). Results: A total of 237 patients (mean age 51.6 years; 57.0% male) were included in the study. There were 55 deaths, 21 from cardiovascular causes. For patients with a CHA2DS2-VASc score >2, the unadjusted hazard of all-cause mortality was doubled (HR = 2.05; 95% CI: 1.20, 3.49) compared to those with a score ≤2, and the risk for cardiovascular deaths was more than threefold (HR = 3.53; 95% CI: 1.46, 8.54). These ratios remained consistent after adjusting for covariates. In the most comprehensive Cox model, the HR for all-cause mortality was 2.43 (95% CI: 1.38, 4.23) and for cardiovascular mortality was 3.52 (95% CI: 1.40, 8.84), similar to results from the modified CHA2DS2-VASc score. Conclusions: The results support the CHA2DS2-VASc score as a practical tool for identifying MHD patients at higher risk of mortality, especially from cardiovascular causes.